Wells Fargo analyst Connor Siversky resumed coverage of Healthpeak Properties with an Equal Weight rating and $19 price target. The firm views Healthpeak Properties’ balance sheet composition, limited Life Science lease roll, Outpatient Medical stability favorably. However, the impact of supply growth in Life Science remains a key element of uncertainty, Wells adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties resumed with an Outperform at RBC Capital
- Healthpeak Properties price target lowered to $22 from $23 at Scotiabank
- Healthpeak Properties resumed with Neutral from Overweight at JPMorgan
- Physicians Realty Trust Acquisition and Financial Restructuring
- American Homes 4 Rent to replace Physicians Realty Trust in the S&P 400
